Inovio Pharmaceuticals (INO) News Today → get a piece of the profit from this land (From True Market Insiders) (Ad) Free INO Stock Alerts $12.00 -0.79 (-6.18%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 11:09 PM | msn.comINOVIO Reports First Quarter Financials, Prepares for Major Drug SubmissionsMay 17 at 2:12 AM | americanbankingnews.comResearch Analysts Offer Predictions for Inovio Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:INO)May 16 at 7:26 AM | marketbeat.comQ2 2024 Earnings Forecast for Inovio Pharmaceuticals, Inc. Issued By HC Wainwright (NASDAQ:INO)Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Free Report) - Investment analysts at HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for Inovio Pharmaceuticals in a research report issued on Tuesday, May 14th. HC Wainwright analyst R. Selvaraju now anticipates that the biophaMay 16 at 4:28 AM | americanbankingnews.comInovio Pharmaceuticals (NASDAQ:INO) Now Covered by StephensMay 16 at 3:02 AM | americanbankingnews.comInovio Pharmaceuticals, Inc. Forecasted to Earn Q1 2025 Earnings of ($1.16) Per Share (NASDAQ:INO)May 15, 2024 | marketbeat.comQ1 2025 Earnings Forecast for Inovio Pharmaceuticals, Inc. Issued By HC Wainwright (NASDAQ:INO)Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Free Report) - Analysts at HC Wainwright issued their Q1 2025 EPS estimates for Inovio Pharmaceuticals in a research note issued to investors on Tuesday, May 14th. HC Wainwright analyst R. Selvaraju expects that the biopharmaceutical company will post eaMay 15, 2024 | americanbankingnews.comShort Interest in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Drops By 10.2%May 15, 2024 | marketbeat.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest UpdateInovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totalling 2,030,000 shares, a decrease of 10.2% from the April 15th total of 2,260,000 shares. Based on an average trading volume of 456,400 shares, the days-to-cover ratio is currently 4.4 days. Approximately 7.9% of the shares of the stock are short sold.May 15, 2024 | finanznachrichten.deINOVIO Pharmaceuticals, Inc.: INOVIO Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 14, 2024 | msn.comStephens & Co. Initiates Coverage of Inovio Pharmaceuticals (INO) with Overweight RecommendationMay 14, 2024 | markets.businessinsider.comDNA Medicine Focused INOVIO Pharma Efficiencies Implemented By Leadership Will Help De-Risk Its Platform Technology: AnalystMay 14, 2024 | markets.businessinsider.comInovio Pharmaceuticals: Hold Rating Amidst Clinical Progress and Financial CautionMay 14, 2024 | marketbeat.comInovio Pharmaceuticals (NASDAQ:INO) Releases Earnings Results, Misses Expectations By $0.23 EPSInovio Pharmaceuticals (NASDAQ:INO - Get Free Report) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($1.31) EPS for the quarter, missing analysts' consensus estimates of ($1.08) by ($0.23). Inovio Pharmaceuticals had a negative return on equity of 79.86% and a negative net margin of 16,238.91%. During the same period in the previous year, the business posted ($1.92) earnings per share.May 14, 2024 | insidermonkey.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2024 Earnings Call TranscriptMay 14, 2024 | marketbeat.comInovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated by Analysts at StephensStephens initiated coverage on Inovio Pharmaceuticals in a research note on Tuesday. They issued an "overweight" rating and a $20.00 target price for the company.May 14, 2024 | finance.yahoo.comInovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 13, 2024 | investorplace.comINO Stock Earnings: Inovio Pharmaceuticals Misses EPS for Q1 2024May 13, 2024 | nasdaq.comInovio Pharmaceuticals Inc. Q1 Loss DeclinesMay 13, 2024 | sfgate.comInovio: Q1 Earnings SnapshotMay 13, 2024 | prnewswire.comINOVIO Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 12, 2024 | msn.comInovio Pharmaceuticals Q1 2024 Earnings PreviewMay 12, 2024 | markets.businessinsider.comInovio Pharmaceuticals earnings: here's what Wall Street expectsMay 11, 2024 | americanbankingnews.comInovio Pharmaceuticals (INO) to Release Quarterly Earnings on MondayMay 6, 2024 | msn.comINOVIO Awards Equity Grants to New Employees Under 2022 Inducement PlanMay 6, 2024 | marketbeat.comInovio Pharmaceuticals (INO) to Release Earnings on MondayInovio Pharmaceuticals (NASDAQ:INO) will be releasing earnings after the market closes on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=383119)May 5, 2024 | fool.comThis Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?May 1, 2024 | prnewswire.comINOVIO Reports Inducement Grants Under Inducement PlanApril 29, 2024 | prnewswire.comINOVIO to Report First Quarter 2024 Financial Results on May 13, 2024April 29, 2024 | prnewswire.comINOVIO to Participate in Upcoming Investor Conferences in MayApril 25, 2024 | finance.yahoo.comPharmaJet’s needle-free delivery system proves effective in published studyApril 25, 2024 | seekingalpha.comInovio Pharmaceuticals: The Dilution ContinuesApril 22, 2024 | finance.yahoo.comGlobal COVID-19 Vaccines Research Report 2023-2025 - Licensing and Partnership Deals Worldwide Propel Vaccine ProductionApril 16, 2024 | bizjournals.comInovio set to raise $36M following 'strategic refocus'April 15, 2024 | markets.businessinsider.comInovio Announces Pricing Of About $36 Mln Offering Of Stock And Pre-Funded Warrants; Stock DropsApril 15, 2024 | prnewswire.comINOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsApril 5, 2024 | marketbeat.comInovio Pharmaceuticals (NASDAQ:INO) Rating Lowered to Sell at StockNews.comStockNews.com lowered shares of Inovio Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Friday.April 2, 2024 | marketbeat.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Sees Large Growth in Short InterestInovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 2,060,000 shares, an increase of 10.8% from the February 29th total of 1,860,000 shares. Currently, 9.0% of the company's shares are short sold. Based on an average daily trading volume, of 526,600 shares, the days-to-cover ratio is currently 3.9 days.April 2, 2024 | msn.comINOVIO's Leadership to Spotlight Innovative Disease-Fighting Technologies at Citizens JMP Novel Therapeutics ForumMarch 29, 2024 | finance.yahoo.comGlobal Human Vaccines Market (2023-2028)March 26, 2024 | prnewswire.comINOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn MedicineMarch 18, 2024 | marketbeat.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Up 6.9% in FebruaryInovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) saw a significant increase in short interest in the month of February. As of February 29th, there was short interest totalling 1,860,000 shares, an increase of 6.9% from the February 14th total of 1,740,000 shares. Based on an average daily trading volume, of 474,800 shares, the days-to-cover ratio is presently 3.9 days. Approximately 8.1% of the company's shares are short sold.March 11, 2024 | benzinga.comPeering Into Inovio Pharmaceuticals's Recent Short InterestMarch 11, 2024 | marketbeat.comBrokers Set Expectations for Inovio Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:INO)Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Free Report) - Research analysts at HC Wainwright reduced their Q1 2024 EPS estimates for Inovio Pharmaceuticals in a research note issued to investors on Thursday, March 7th. HC Wainwright analyst R. Selvaraju now expects that the biopharmaceutical compMarch 10, 2024 | ca.finance.yahoo.comINO Mar 2024 6.500 callMarch 7, 2024 | markets.businessinsider.comInovio Pharmaceuticals: Hold Rating with Promising Pipeline Despite Financial LossesMarch 7, 2024 | finance.yahoo.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | marketbeat.comInovio Pharmaceuticals (NASDAQ:INO) Given Sector Perform Rating at Royal Bank of CanadaRoyal Bank of Canada restated a "sector perform" rating and set a $11.00 price target on shares of Inovio Pharmaceuticals in a research note on Thursday.March 7, 2024 | finance.yahoo.comQ4 2023 Inovio Pharmaceuticals Inc Earnings CallMarch 7, 2024 | fool.comInovio Pharmaceuticals (INO) Q4 2023 Earnings Call TranscriptMarch 6, 2024 | benzinga.comRecap: Inovio Pharmaceuticals Q4 Earnings Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (Ad)Man who spotted Apple at $1.49 says: "Buy These 6 AI Stocks." And these will be the biggest winners INO Media Mentions By Week INO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INO News Sentiment▼0.270.42▲Average Medical News Sentiment INO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INO Articles This Week▼302▲INO Articles Average Week Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TriSalus Life Sciences News Utah Medical Products News AngioDynamics News AVITA Medical News Sight Sciences News Fractyl Health News Profound Medical News Cerus News Orchestra BioMed News Tactile Systems Technology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 Media[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
